Skip to main content
Top
Published in: BMC Pediatrics 1/2019

Open Access 01-12-2019 | Etanercept | Case report

Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report

Authors: Po-Yu Huang, Ling-Sai Chang, Mindy Ming-Huey Guo, Ho-Chang Kuo

Published in: BMC Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

Although the sternoclavicular joint (SCJ) may be involved in ankylosing spondylitis, rheumatic arthritis, and Behçet’s disease and participates in the systemic inflammatory process of arthritis, it is often neglected during routine rheumatologic clinical examinations. To the best of our knowledge, this is the first study to report etanercept treatment in juvenile idiopathic arthritis (JIA) with SCJ involvement.

Case presentation

In this study, we describe an unusual case of a child with juvenile idiopathic arthritis with an initial presentation of sternoclavicular mass. The patient (age, 14 years 10 months) presented with an insidious onset atraumatic swelling of the left SCJ and complained of right hip and bilateral ankle tenderness without an apparent cause. Initial ultrasonography indicated a heterogeneous mass in the left SCJ, while computed tomography identified mild swelling of the left SCJ with a thickened synovial lining, mild bone erosion, and some turbid fluid. The patient ultimately underwent left SCJ arthrotomy, during which tapping of the SCJ revealed 2 cc of yellowish fluid, inflammation and necrosis of tissues within the SCJ. A clear yellow joint fluid was aspirated, and testing revealed a negative culture result. The patient was diagnosed with JIA. The joint tenderness improved and erythrocyte sedimentation rate decreased after administering anti-tumor necrosis factor etanercept. An additional ultrasonography demonstrated that the initial imaging findings have been resolved. At the end of a 2-year follow-up period, the patient was completely symptom-free.

Conclusions

JIA with SCJ involvement is an uncommon presentation in adolescents. Etanercept may be a beneficial treatment for SCJ involvement in patients with JIA. The upper limbs showed no signs of limited range of motion during the follow-up period. Further studies are warranted to elucidate the efficacy of etanercept in JIA with sternoclavicular joint involvement.
Literature
1.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
2.
go back to reference Goirand M, Breton S, Chevallier F, Duong NP, Uettwiller F, Melki I, et al. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology Centre. Pediatr Rheumatol Online J. 2018;16:21.CrossRef Goirand M, Breton S, Chevallier F, Duong NP, Uettwiller F, Melki I, et al. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology Centre. Pediatr Rheumatol Online J. 2018;16:21.CrossRef
3.
go back to reference Shen CC, Yeh KW, Ou LS, Yao TC, Chen LC, Huang JL. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol Immunol Infect. 2013;46:288–94.CrossRef Shen CC, Yeh KW, Ou LS, Yao TC, Chen LC, Huang JL. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol Immunol Infect. 2013;46:288–94.CrossRef
4.
go back to reference Giancane G, Alongi A, Ravelli A. Update on the pathogenesis and treatment of juvenile idiopathic arthritis. Curr Opin Rheumatol. 2017;29:523–9.CrossRef Giancane G, Alongi A, Ravelli A. Update on the pathogenesis and treatment of juvenile idiopathic arthritis. Curr Opin Rheumatol. 2017;29:523–9.CrossRef
5.
go back to reference Filaci G, Rizzi M, Setti M, Fenoglio D, Fravega M, Basso M, et al. Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci. 2005;1050:115–23.CrossRef Filaci G, Rizzi M, Setti M, Fenoglio D, Fravega M, Basso M, et al. Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci. 2005;1050:115–23.CrossRef
6.
go back to reference Silverman ED, Somma C, Khan MM, Melmon KL, Engleman EG. Abnormal T suppressor cell function in juvenile rheumatoid arthritis. Arthritis Rheum. 1990;33:205–11.CrossRef Silverman ED, Somma C, Khan MM, Melmon KL, Engleman EG. Abnormal T suppressor cell function in juvenile rheumatoid arthritis. Arthritis Rheum. 1990;33:205–11.CrossRef
7.
go back to reference Ichikawa M, Yanagisawa M, Kawai H, Kamijo T, Komiyama A, Akabane T. Spontaneous improvement of juvenile rheumatoid arthritis after T lymphocytosis with suppressor phenotype and function. J Clin Lab Immunol. 1988;27:197–201.PubMed Ichikawa M, Yanagisawa M, Kawai H, Kamijo T, Komiyama A, Akabane T. Spontaneous improvement of juvenile rheumatoid arthritis after T lymphocytosis with suppressor phenotype and function. J Clin Lab Immunol. 1988;27:197–201.PubMed
8.
go back to reference Robinson CM, Jenkins PJ, Markham PE, Beggs I. Disorders of the sternoclavicular joint. J Bone Joint Surg Br. 2008;90:685–96.CrossRef Robinson CM, Jenkins PJ, Markham PE, Beggs I. Disorders of the sternoclavicular joint. J Bone Joint Surg Br. 2008;90:685–96.CrossRef
9.
go back to reference Joseph F, Ahmad S, Dehnavi A, Ismail F. Bilateral sternoclavicular synovial cysts in juvenile idiopathic arthritis. SA Orthop J. 2010;9:72–5. Joseph F, Ahmad S, Dehnavi A, Ismail F. Bilateral sternoclavicular synovial cysts in juvenile idiopathic arthritis. SA Orthop J. 2010;9:72–5.
10.
go back to reference Mondal S, Sinha D, Nag A, Ghosh A. Unilateral sternocostoclavicular hyperostosis in a patient with ankylosing spondylitis: a case report with color Doppler ultrasonogram findings. Indian J Radiol Imaging. 2013;23:278–80.CrossRef Mondal S, Sinha D, Nag A, Ghosh A. Unilateral sternocostoclavicular hyperostosis in a patient with ankylosing spondylitis: a case report with color Doppler ultrasonogram findings. Indian J Radiol Imaging. 2013;23:278–80.CrossRef
11.
go back to reference Colbert RA. Classification of juvenile spondyloarthritis: enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6:477–85.CrossRef Colbert RA. Classification of juvenile spondyloarthritis: enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6:477–85.CrossRef
12.
go back to reference Sampaio-Barros PD, Bertolo MB, Kraemer MH, Neto JF, Samara AM. Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol. 2001;28:560–5.PubMed Sampaio-Barros PD, Bertolo MB, Kraemer MH, Neto JF, Samara AM. Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol. 2001;28:560–5.PubMed
13.
go back to reference Matuszewska G, Zaniewicz-Kaniewska K, Wlodkowska-Korytkowska M, Smorawinska P, Saied F, Kunisz W, et al. Radiological imaging in pediatric rheumatic diseases. Pol J Radiol. 2014;79:51–8.CrossRef Matuszewska G, Zaniewicz-Kaniewska K, Wlodkowska-Korytkowska M, Smorawinska P, Saied F, Kunisz W, et al. Radiological imaging in pediatric rheumatic diseases. Pol J Radiol. 2014;79:51–8.CrossRef
14.
go back to reference Burgos-Vargas R, Vazquez-Mellado J, Cassis N, Duarte C, Casarin J, Cifuentes M, et al. Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria. J Rheumatol. 1996;23:2140–7.PubMed Burgos-Vargas R, Vazquez-Mellado J, Cassis N, Duarte C, Casarin J, Cifuentes M, et al. Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria. J Rheumatol. 1996;23:2140–7.PubMed
15.
go back to reference Rodriguez-Henriquez P, Solano C, Pena A, Leon-Hernandez S, Hernandez-Diaz C, Gutierrez M, et al. Sternoclavicular joint involvement in rheumatoid arthritis: clinical and ultrasound findings of a neglected joint. Arthritis Care Res (Hoboken). 2013;65:1177–82.CrossRef Rodriguez-Henriquez P, Solano C, Pena A, Leon-Hernandez S, Hernandez-Diaz C, Gutierrez M, et al. Sternoclavicular joint involvement in rheumatoid arthritis: clinical and ultrasound findings of a neglected joint. Arthritis Care Res (Hoboken). 2013;65:1177–82.CrossRef
16.
go back to reference Frikha F, Marzouk S, Kaddour N, Frigui M, Bahloul Z. Destructive arthritis in Behcet's disease: a report of eight cases and literature review. Int J Rheum Dis. 2009;12:250–5.CrossRef Frikha F, Marzouk S, Kaddour N, Frigui M, Bahloul Z. Destructive arthritis in Behcet's disease: a report of eight cases and literature review. Int J Rheum Dis. 2009;12:250–5.CrossRef
17.
go back to reference Pourcho AM, Sellon JL, Smith J. Sonographically guided sternoclavicular joint injection: description of technique and validation. J Ultrasound Med. 2015;34:325–31.CrossRef Pourcho AM, Sellon JL, Smith J. Sonographically guided sternoclavicular joint injection: description of technique and validation. J Ultrasound Med. 2015;34:325–31.CrossRef
18.
go back to reference Kuo HC, Yu HR, Wu CC, Chang LS, Yang KD. Etanercept treatment for children with refractory juvenile idiopathic arthritis. J Microbiol Immunol Infect. 2011;44:52–6.CrossRef Kuo HC, Yu HR, Wu CC, Chang LS, Yang KD. Etanercept treatment for children with refractory juvenile idiopathic arthritis. J Microbiol Immunol Infect. 2011;44:52–6.CrossRef
20.
go back to reference Kemper AR, Van Mater HA, Coeytaux RR, Williams JW Jr, Sanders GD. Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis. BMC Pediatr. 2012;12:1471–2431.CrossRef Kemper AR, Van Mater HA, Coeytaux RR, Williams JW Jr, Sanders GD. Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis. BMC Pediatr. 2012;12:1471–2431.CrossRef
21.
go back to reference Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000;342:763–9.CrossRef Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000;342:763–9.CrossRef
22.
go back to reference Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R, et al. Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Mod Rheumatol. 2018;28:417–31.CrossRef Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R, et al. Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Mod Rheumatol. 2018;28:417–31.CrossRef
23.
go back to reference Foeldvari I, Constantin T, Vojinovic J, Horneff G, Chasnyk V, Dehoorne J, et al. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Res Ther. 2019;21:125.CrossRef Foeldvari I, Constantin T, Vojinovic J, Horneff G, Chasnyk V, Dehoorne J, et al. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Res Ther. 2019;21:125.CrossRef
24.
go back to reference Amarilyo G, Tarp S, Foeldvari I, Cohen N, Pope TD, Woo JM, et al. Biological agents in polyarticular juvenile idiopathic arthritis: a meta-analysis of randomized withdrawal trials. Semin Arthritis Rheum. 2016;46:312–8.CrossRef Amarilyo G, Tarp S, Foeldvari I, Cohen N, Pope TD, Woo JM, et al. Biological agents in polyarticular juvenile idiopathic arthritis: a meta-analysis of randomized withdrawal trials. Semin Arthritis Rheum. 2016;46:312–8.CrossRef
25.
go back to reference Davies R, Gaynor D, Hyrich KL, Pain CE. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum. 2017;46:584–93.CrossRef Davies R, Gaynor D, Hyrich KL, Pain CE. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum. 2017;46:584–93.CrossRef
26.
go back to reference Murdaca G, Negrini S, Pellecchio M, Greco M, Schiavi C, Giusti F, et al. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opin Drug Saf. 2019;18:219–29.CrossRef Murdaca G, Negrini S, Pellecchio M, Greco M, Schiavi C, Giusti F, et al. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opin Drug Saf. 2019;18:219–29.CrossRef
27.
go back to reference Hsin YC, Zhuang LZ, Yeh KW, Chang CW, Horng JT, Huang JL. Risk of tuberculosis in children with juvenile idiopathic arthritis: a nationwide population-based study in Taiwan. PLoS One. 2015;10:e0128768.CrossRef Hsin YC, Zhuang LZ, Yeh KW, Chang CW, Horng JT, Huang JL. Risk of tuberculosis in children with juvenile idiopathic arthritis: a nationwide population-based study in Taiwan. PLoS One. 2015;10:e0128768.CrossRef
28.
go back to reference Lin KC, Liang CD, Yang KD, Yu HR, Kuo HC. Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment. Rheumatol Int. 2012;32:1383–5.CrossRef Lin KC, Liang CD, Yang KD, Yu HR, Kuo HC. Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment. Rheumatol Int. 2012;32:1383–5.CrossRef
29.
go back to reference Guo MM, Yang KD, Yu HR, Kuo HC. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis. The J Rheumatol. 2011;38:577–9.CrossRef Guo MM, Yang KD, Yu HR, Kuo HC. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis. The J Rheumatol. 2011;38:577–9.CrossRef
30.
go back to reference Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014;12:1546–0096.CrossRef Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014;12:1546–0096.CrossRef
31.
go back to reference Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34:1839–46.CrossRef Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34:1839–46.CrossRef
32.
go back to reference Wintrich S, Horneff G. Characteristics and outcomes of chronic non-bacterial osteitis in children. Eur J Rheumatol. 2015;2:139–42.CrossRef Wintrich S, Horneff G. Characteristics and outcomes of chronic non-bacterial osteitis in children. Eur J Rheumatol. 2015;2:139–42.CrossRef
Metadata
Title
Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report
Authors
Po-Yu Huang
Ling-Sai Chang
Mindy Ming-Huey Guo
Ho-Chang Kuo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2019
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-019-1770-6

Other articles of this Issue 1/2019

BMC Pediatrics 1/2019 Go to the issue